News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alimera Sciences (ALIM) Re-Files for IPO


11/2/2009 8:11:26 AM

pehub.com -- Alimera Sciences Inc., an Atlanta-based ophthalmic pharmaceutical company, has filed for an $80 million IPO. This comes less than two months after Alimera withdrew registration for a $75 million IPO due to “current public market conditions.”


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES